- call +1-201-465-4211
- email sales@mrinsights.biz
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
Scope of the Report:
This report focuses on the Cardiac Biomarkers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.
There is a high demand for cardiac biomarkers due to their proficiency and the ability to provide accurate results. The number of clinical trials conducted for cardiac biomarkers is steadily increasing since manufactures, universities, and research institutes are focused on improving the efficiency and efficacy of the biomarkers. Cardiac biomarker manufacturers are increasingly focusing on R&D to perform several clinical trials to prove the effectiveness of the products and increase their consumer base. According to our industry research and analysis, the increase in number of clinical trials will be one of the key trends that will gain traction in the cardiac biomarkers market during the next few years.
North America leads the global market, owing to the high demand for cardiac testing, high CVD prevalence rate and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to the modernization, increasing disposable incomes and rising affordability for the advanced cardiac treatments.
The worldwide market for Cardiac Biomarkers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Abbott
Alere
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
Market Segment by Applications, can be divided into
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
There are 15 Chapters to deeply display the global Cardiac Biomarkers market.
Chapter 1, to describe Cardiac Biomarkers Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiac Biomarkers, with sales, revenue, and price of Cardiac Biomarkers, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiac Biomarkers, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cardiac Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cardiac Biomarkers sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cardiac Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Troponin
1.2.2 CK-MB
1.2.3 Natriuretic Peptides - BNP and NT-proBNP
1.2.4 Myoglobin
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Acute Coronary Syndrome
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Cardiac Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alere
2.2.1 Business Overview
2.2.2 Cardiac Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alere Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Cardiac Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Advanced ImmunoChemical
2.4.1 Business Overview
2.4.2 Cardiac Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Advanced ImmunoChemical Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AgPlus Diagnostics
2.5.1 Business Overview
2.5.2 Cardiac Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AgPlus Diagnostics Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BG Medicine
2.6.1 Business Overview
2.6.2 Cardiac Biomarkers Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BG Medicine Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 BioLegend
2.7.1 Business Overview
2.7.2 Cardiac Biomarkers Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BioLegend Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 bioMérieux
2.8.1 Business Overview
2.8.2 Cardiac Biomarkers Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 bioMérieux Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bio-Rad Laboratories
2.9.1 Business Overview
2.9.2 Cardiac Biomarkers Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bio-Rad Laboratories Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 BODITECH MED
2.10.1 Business Overview
2.10.2 Cardiac Biomarkers Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 BODITECH MED Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cardiac Biomarkers Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cardiac Biomarkers Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cardiac Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cardiac Biomarkers Manufacturer Market Share in 2017
3.3.2 Top 6 Cardiac Biomarkers Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cardiac Biomarkers Market Analysis by Regions
4.1 Global Cardiac Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Cardiac Biomarkers Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cardiac Biomarkers Revenue and Market Share by Regions (2013-2018)
4.2 North America Cardiac Biomarkers Sales and Growth Rate (2013-2018)
4.3 Europe Cardiac Biomarkers Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cardiac Biomarkers Sales and Growth Rate (2013-2018)
4.5 South America Cardiac Biomarkers Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cardiac Biomarkers Sales and Growth Rate (2013-2018)
5 North America Cardiac Biomarkers by Countries
5.1 North America Cardiac Biomarkers Sales, Revenue and Market Share by Countries
5.1.1 North America Cardiac Biomarkers Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cardiac Biomarkers Revenue and Market Share by Countries (2013-2018)
5.2 United States Cardiac Biomarkers Sales and Growth Rate (2013-2018)
5.3 Canada Cardiac Biomarkers Sales and Growth Rate (2013-2018)
5.4 Mexico Cardiac Biomarkers Sales and Growth Rate (2013-2018)
6 Europe Cardiac Biomarkers by Countries
6.1 Europe Cardiac Biomarkers Sales, Revenue and Market Share by Countries
6.1.1 Europe Cardiac Biomarkers Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cardiac Biomarkers Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cardiac Biomarkers Sales and Growth Rate (2013-2018)
6.3 UK Cardiac Biomarkers Sales and Growth Rate (2013-2018)
6.4 France Cardiac Biomarkers Sales and Growth Rate (2013-2018)
6.5 Russia Cardiac Biomarkers Sales and Growth Rate (2013-2018)
6.6 Italy Cardiac Biomarkers Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cardiac Biomarkers by Countries
7.1 Asia-Pacific Cardiac Biomarkers Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cardiac Biomarkers Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cardiac Biomarkers Revenue and Market Share by Countries (2013-2018)
7.2 China Cardiac Biomarkers Sales and Growth Rate (2013-2018)
7.3 Japan Cardiac Biomarkers Sales and Growth Rate (2013-2018)
7.4 Korea Cardiac Biomarkers Sales and Growth Rate (2013-2018)
7.5 India Cardiac Biomarkers Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cardiac Biomarkers Sales and Growth Rate (2013-2018)
8 South America Cardiac Biomarkers by Countries
8.1 South America Cardiac Biomarkers Sales, Revenue and Market Share by Countries
8.1.1 South America Cardiac Biomarkers Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cardiac Biomarkers Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cardiac Biomarkers Sales and Growth Rate (2013-2018)
8.3 Argentina Cardiac Biomarkers Sales and Growth Rate (2013-2018)
8.4 Colombia Cardiac Biomarkers Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cardiac Biomarkers by Countries
9.1 Middle East and Africa Cardiac Biomarkers Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cardiac Biomarkers Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cardiac Biomarkers Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cardiac Biomarkers Sales and Growth Rate (2013-2018)
9.3 UAE Cardiac Biomarkers Sales and Growth Rate (2013-2018)
9.4 Egypt Cardiac Biomarkers Sales and Growth Rate (2013-2018)
9.5 Nigeria Cardiac Biomarkers Sales and Growth Rate (2013-2018)
9.6 South Africa Cardiac Biomarkers Sales and Growth Rate (2013-2018)
10 Global Cardiac Biomarkers Market Segment by Type
10.1 Global Cardiac Biomarkers Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cardiac Biomarkers Sales and Market Share by Type (2013-2018)
10.1.2 Global Cardiac Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Troponin Sales Growth and Price
10.2.1 Global Troponin Sales Growth (2013-2018)
10.2.2 Global Troponin Price (2013-2018)
10.3 CK-MB Sales Growth and Price
10.3.1 Global CK-MB Sales Growth (2013-2018)
10.3.2 Global CK-MB Price (2013-2018)
10.4 Natriuretic Peptides - BNP and NT-proBNP Sales Growth and Price
10.4.1 Global Natriuretic Peptides - BNP and NT-proBNP Sales Growth (2013-2018)
10.4.2 Global Natriuretic Peptides - BNP and NT-proBNP Price (2013-2018)
10.5 Myoglobin Sales Growth and Price
10.5.1 Global Myoglobin Sales Growth (2013-2018)
10.5.2 Global Myoglobin Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Cardiac Biomarkers Market Segment by Application
11.1 Global Cardiac Biomarkers Sales Market Share by Application (2013-2018)
11.2 Acute Coronary Syndrome Sales Growth (2013-2018)
11.3 Myocardial Infarction Sales Growth (2013-2018)
11.4 Congestive Heart Failure Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Cardiac Biomarkers Market Forecast (2018-2023)
12.1 Global Cardiac Biomarkers Sales, Revenue and Growth Rate (2018-2023)
12.2 Cardiac Biomarkers Market Forecast by Regions (2018-2023)
12.2.1 North America Cardiac Biomarkers Market Forecast (2018-2023)
12.2.2 Europe Cardiac Biomarkers Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cardiac Biomarkers Market Forecast (2018-2023)
12.2.4 South America Cardiac Biomarkers Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cardiac Biomarkers Market Forecast (2018-2023)
12.3 Cardiac Biomarkers Market Forecast by Type (2018-2023)
12.3.1 Global Cardiac Biomarkers Sales Forecast by Type (2018-2023)
12.3.2 Global Cardiac Biomarkers Market Share Forecast by Type (2018-2023)
12.4 Cardiac Biomarkers Market Forecast by Application (2018-2023)
12.4.1 Global Cardiac Biomarkers Sales Forecast by Application (2018-2023)
12.4.2 Global Cardiac Biomarkers Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cardiac Biomarkers Picture
Table Product Specifications of Cardiac Biomarkers
Figure Global Sales Market Share of Cardiac Biomarkers by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
